NEOFECT Co (XKRX:290660) Cash-to-Debt : 1.13 (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is NEOFECT Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. NEOFECT Co's cash to debt ratio for the quarter that ended in Dec. 2024 was 1.13.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, NEOFECT Co could pay off its debt using the cash in hand for the quarter that ended in Dec. 2024.

The historical rank and industry rank for NEOFECT Co's Cash-to-Debt or its related term are showing as below:

XKRX:290660' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.09 Med: 0.95 Max: 11.91
Current: 1.13

During the past 9 years, NEOFECT Co's highest Cash to Debt Ratio was 11.91. The lowest was 0.09. And the median was 0.95.

XKRX:290660's Cash-to-Debt is ranked worse than
56.64% of 858 companies
in the Medical Devices & Instruments industry
Industry Median: 1.73 vs XKRX:290660: 1.13

NEOFECT Co Cash-to-Debt Historical Data

The historical data trend for NEOFECT Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

NEOFECT Co Cash-to-Debt Chart

NEOFECT Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash-to-Debt

Get a 7-Day Free Trial

0.59

0.24

0.09

0.95

1.13

NEOFECT Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash-to-Debt	Get a 7-Day Free Trial															0.95	0.85	0.82	0.97	1.13

Competitive Comparison of NEOFECT Co's Cash-to-Debt

For the Medical Devices subindustry, NEOFECT Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NEOFECT Co's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NEOFECT Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where NEOFECT Co's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

NEOFECT Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

NEOFECT Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	27261.584	/	(19731.777	+	4493.444)
	=	1.13

NEOFECT Co's Cash to Debt Ratio for the quarter that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	27261.584	/	(19731.777	+	4493.444)
	=	1.13

NEOFECT Co (XKRX:290660) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

NEOFECT Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of NEOFECT Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

NEOFECT Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NEOFECT Co Ltd (XKRX:290660) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

152, Jukjeon-ro, 401 West Hall, Dankook, University, 152, Suji-gu, Gyeonggi-do, Yongin-si, KOR

Website

http://www.neofect.com

NEOFECT Co Ltd is a Korea based company engaged in developing rehab training products and services. The company has developed innovative smart rehabilitation solutions to help patients with neurological and musculoskeletal injuries. Products offered by the company include RAPAEL Smart Glove, RAPAEL Smart Kids, RAPAEL Smart Board, RAPAEL SMART PEGBOARD, RAPAEL Cognition, NeoMano, and RAPAEL Suite.

NEOFECT Co Headlines

No Headlines